Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

BabyScreen+ newborn screening

Gene: CLN5

Amber List (moderate evidence)

CLN5 (CLN5, intracellular trafficking protein)
EnsemblGeneIds (GRCh38): ENSG00000102805
EnsemblGeneIds (GRCh37): ENSG00000102805
OMIM: 608102, Gene2Phenotype
CLN5 is in 13 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Well established gene-disease association.

Severe neurodegenerative disorder of childhood onset.

No specific treatment. Note clinical trials under way.
Created: 5 Oct 2022, 9:38 p.m. | Last Modified: 5 Oct 2022, 9:38 p.m.
Panel Version: 0.300

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Ceroid lipofuscinosis, neuronal, 5, MIM# 256731; MONDO:0009745

John Christodoulou (Murdoch Children's Research Institute)

I don't know

Tend to present later than CLN3 - 4 - 7 yr

Gene therapy trials in sheep promising. Recently approved by the FDA for clinical trials

PMID: 33242182
Created: 28 Sep 2022, 4:06 a.m. | Last Modified: 28 Sep 2022, 4:06 a.m.
Panel Version: 0.266

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • BabySeq Category A gene
Phenotypes
  • Ceroid lipofuscinosis, neuronal, 5, MIM# 256731
  • MONDO:0009745
Tags
clinical trial
OMIM
608102
Clinvar variants
Variants in CLN5
Penetrance
None
Panels with this gene

History Filter Activity

28 Jul 2024, Gel status: 2

Set Phenotypes

Tommy Li (Murdoch Children's Research Institute)

Added phenotypes Ceroid lipofuscinosis, neuronal, 5, MIM# 256731; MONDO:0009745 for gene: CLN5

2 Nov 2022, Gel status: 2

Removed Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag for review was removed from gene: CLN5.

5 Oct 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cln5 has been classified as Amber List (Moderate Evidence).

5 Oct 2022, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: CLN5 were changed from Ceroid lipofuscinosis, neuronal, 5 to Ceroid lipofuscinosis, neuronal, 5, MIM# 256731; MONDO:0009745

5 Oct 2022, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cln5 has been classified as Amber List (Moderate Evidence).

5 Oct 2022, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag for review tag was added to gene: CLN5. Tag clinical trial tag was added to gene: CLN5.

18 Sep 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: CLN5 was added gene: CLN5 was added to gNBS. Sources: BabySeq Category A gene,Expert Review Green Mode of inheritance for gene: CLN5 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CLN5 were set to Ceroid lipofuscinosis, neuronal, 5